Psilocybin Tied to Lower Inflammation in Parkinson's Trial
(MedPage Today) -- Markers of systemic inflammation and mitochondrial stress were reduced after psilocybin therapy in Parkinson's disease patients with mood dysfunction, a small nonrandomized trial showed. Relative to baseline, an inflammatory...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.